Trial Profile
Nicotinamide, vitamin B3. Metabolic pathways in patients with early Parkinson's disease
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2005
Price :
$35
*
At a glance
- Drugs Nicotinamide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 15 Jul 2005 New trial record.